The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.
Yarrow (Achillea millefolium) is a flowering plant that has been used in traditional medicine across various cultures for centuries. It belongs to the Asteraceae family and is native to temperate regions of the Northern Hemisphere. This review synthesizes current scientific understanding of yarrow's therapeutic properties based on peer-reviewed literature.
The primary species discussed in scientific literature is Achillea millefolium L., commonly known as yarrow, common yarrow, milfoil, thousand-leaf, soldier's woundwort, or nosebleed plant. Other Achillea species that have been studied include A. asiatica, A. wilhelmsii, and A. filipendulina. It's important to note that plants sometimes mistakenly identified as yarrow include Queen Anne's lace (Daucus carota) and tansy (Tanacetum vulgare), which have similar appearance but different chemical compositions and therapeutic profiles.
Yarrow contains numerous bioactive compounds including flavonoids (apigenin, luteolin, rutin), sesquiterpene lactones (achillein, achillin), volatile oils (chamazulene, camphor, borneol), alkaloids, coumarins, tannins, and triterpenes. The concentration of these compounds varies based on geographic location, harvest time, and plant part used.
Dosage recommendations vary based on preparation form and intended use. Current scientific literature suggests:
It's important to note that standardization varies significantly between commercial products, and many studies do not adequately report standardization parameters, creating challenges for establishing precise therapeutic dosing recommendations.
Limited research exists on doses significantly exceeding the therapeutic recommendations. A few toxicological studies have examined higher concentrations, finding:
Currently, no evidence supports therapeutic benefits from exceeding recommended dosages, while potential risks increase. The therapeutic window appears to be relatively well-defined within the ranges outlined in the dosage section.
Current scientific evidence supports several traditional uses of yarrow, particularly for inflammation, wound healing, and gastrointestinal complaints. However, the quality of clinical studies varies considerably, with many being small-scale or preliminary. Further high-quality clinical trials with standardized preparations are needed to establish definitive therapeutic guidelines. The relative safety profile of yarrow at recommended doses appears favorable, though potential drug interactions and contraindications must be considered.
Bashir, S., Noor, A., Zargar, M. I., & Siddiqui, N. A. (2022). Ethnopharmacology, phytochemistry, and biological activities of Achillea millefolium: A comprehensive review. Edible plants in health and diseases: volume II: phytochemical and pharmacological properties, 457-481.
Choudhary, G. P. (2022, October). Pharmacological evaluation for antitussive and antiasthmatic potential of Achillea millefolium flower extracts. In Respiratory Care (Vol. 67, No. Suppl_10, p. 3771721).
Dalili, A., Ebrahimnia Milani, S., Kamali, N., Mohammadi, S., Pakbaz, M., Jamalnia, S., & Sadeghi, M. (2022). Beneficial effects of Achillea millefolium on skin injuries; a literature review. Journal of Essential Oil Research, 34(6), 479-489.
Far, B. F., Behzad, G., & Khalili, H. (2023). Achillea millefolium: Mechanism of action, pharmacokinetic, clinical drug-drug interactions and tolerability. Heliyon, 9(12).
Jangjoo, M., Joshaghani, A., & Tahernejadgatabi, F. (2023). The role of Achillea millefolium in traditional medicine: A review of its use in different cultures. Journal of Multidisciplinary Care, 12(3), 152-156.
Moradi, M., Niazi, A., Abbasi, K., Mollazadeh, S., & Feizabadi, M. N. (2024). The Impact of Achillea Millefolium on Primary Dysmenorrhea and Menstrual bleeding: A Systematic Review. Journal of Midwifery & Reproductive Health, 12(2).
Satari, A. H., Bhat, M. F., Hassan, R., & Masoodi, M. H. (2021). Achillea millefolium E. Mey: Phytochemistry and Pharmacological Profile. Current Traditional Medicine, 7(3), 343-347.
Tiwari, P., Patel, A. K., Dubey, P. K., Gupta, N., Bapna, R., Pyati, A. R., ... & Sharma, J. (2021). Evaluation of Anti-anxiety activity of Achillea millefolium Linn. International Journal of Pharmacy & Life Sciences, 12(1).
Yaşar, B., Bekdaş, M., Düzcü, S. E., Çetinkaya, A., Alışık, M., Yıldırım, A. B., & Bekdaş, M. F. (2024). Effects of Yarrow (Achillea millefolium) Extract on Acute Lung Injury: An Experimental Study.
Zhang, L., Yuan, X., & Peng, Q. (2025). Therapeutic potential of Achillea millefolium L. extract on 7, 12-dimethylbenz (a) anthracene (DMBA)-induced ovary cancer in Wistar rats: a biochemical, molecular and histopathological approach. Toxicology Research, 14(1), tfae235.